-
Planning Phase for a Phase IIa Study of Nilotinib in People with Parkinson's Disease
… trial was open label (no placebo control group), additional research is needed to understand the potential clinical … with The Cure Parkinson's Trust and the Van Andel Research Institute to design a randomized, double-blind, … ; Tanya Simuni, MD ; and Charles Venuto, PharmD . Impact on Diagnosis/Treatment of Parkinson's Disease: If nilotinib is …
-
Studying the Effects of TMEM175 and CTSB on Glucocerebrosidase Activity and Alpha-synuclein Properties
… This grant builds upon the research from a prior grant: Genetic Factors that Influence … (hallmark pathology of PD). Importance of This Research for the Development of a New PD Therapy: The current research will help us determine if TMEM175 and CTSB affect …
-
Coordinated Reset (CR) Stimulation of the Subthalamic Nucleus
… model to make this technique ready for translation into a clinical trial in PD patients. Project Description: … and compared to classical DBS and l-dopa. Relevance to Diagnosis/Treatment of Parkinson’s Disease: Classical DBS … model to make this technique ready for translation into a clinical trial in PD patients. Final Outcome Our …
-
Evaluating the Therapeutic Potential of the Systemic Antagonism of Dopamine Receptor D3
… brain and subsequent brain cell death. Importance of This Research for the Development of a New PD Therapy: This research will allow us to confirm the therapeutic potential … we could advance to human clinical studies. Moreover, this research will give us a deeper insight of the biological …
-
Developing Biosignatures of Parkinson's Disease Using Sense of Smell Supplement
… This grant builds upon the research from a prior grant: Developing Biosignatures of … providing a novel basis for Parkinson's biomarker research. Our customizable MouSensor technology allows us to … super-sniffer mice to advance the identification of early-stage Parkinson's biomarkers in sebum. In a pilot …
-
Development of an MgluR4 PET Radioligand
… disease (PD). Developing an imaging tracer may allow researchers to quantify this receptor in subjects with the … We hypothesize that a radiolabeled compound will allow researchers to measure the quantity of the mglur4 receptor … to evaluate their distribution pre-clinically. Impact on Diagnosis/Treatment of Parkinson’s Disease: …